美股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Palvella Therapeutics

26.97

+3.3814.33%

盘后：26.970.00000.00%18:21 EDT

成交量：6.76万

成交额：178.63万

市值：3.03亿

市盈率：-19.90

高：27.32

开：24.12

低：24.00

收：23.59

数据加载中...

总览公司新闻公告

Palvella Therapeutics Inc 报告截至 12 月 31 日的季度业绩 - 收益摘要

Palvella Therapeutics Inc 预计每股亏损67美分 - 财报前瞻

嗡嗡声--美国股票走势-OrganiGram, Phillips 66, SurgePays

BUZZ-Stifel给予Palvella "买入 "评级，看好皮肤治疗前景

美国研究综述-Carvana、CrowdStrike、Viasat

美国研究综述-美国金融公司、SM 能源、Verizon

Palvella Therapeutics(PVLA.US)获TD Cowen首次覆盖，给予买入评级, 目标价44.00美元。

美国研究综述-苹果、EverQuote、联合健康

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/PVLA/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PVLA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PVLA\",,,,,undefined,":{"symbol":"PVLA","market":"US","secType":"STK","nameCN":"Palvella Therapeutics","latestPrice":26.97,"timestamp":1743624000000,"preClose":23.59,"halted":0,"volume":67554,"hourTrading":{"tag":"盘后","latestPrice":26.97,"preClose":26.97,"latestTime":"18:21 EDT","volume":36,"amount":904.37,"timestamp":1743632512639},"delay":0,"floatShares":6497315,"shares":11221307,"eps":-1.355074,"marketStatus":"未开盘","change":3.38,"latestTime":"04-02 16:00:00 EDT","open":24.12,"high":27.322,"low":24,"amount":1786324.950126,"amplitude":0.140822,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-1.355074,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1743667200000},"marketStatusCode":0,"adr":0,"listingDate":1435636800000,"exchange":"NASDAQ","adjPreClose":23.59,"preHourTrading":{"tag":"盘前","latestPrice":24.69,"preClose":23.59,"latestTime":"04:48 EDT","volume":2,"amount":49.480004,"timestamp":1743583685982},"postHourTrading":{"tag":"盘后","latestPrice":26.97,"preClose":26.97,"latestTime":"18:21 EDT","volume":36,"amount":904.37,"timestamp":1743632512639},"volumeRatio":0.911955,"impliedVol":0.6703,"impliedVolPercentile":0.7333},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PVLA\",,,,,undefined,":{"symbol":"PVLA","floatShares":6497315,"roa":"--","roe":"--","lyrEps":0.679019,"volumeRatio":0.911955,"shares":11221307,"dividePrice":0,"high":27.322,"amplitude":0.140822,"preClose":23.59,"low":24,"week52Low":6.2,"pbRate":"-3.46","week52High":29.27,"institutionHeld":0,"latestPrice":26.97,"eps":-1.355074,"divideRate":0,"volume":67554,"delay":0,"ttmEps":-1.355074,"open":24.12,"prevYearClose":12,"prevWeekClose":28.1,"prevMonthClose":27.99,"prevQuarterClose":27.99,"fiveDayClose":27.93,"twentyDayClose":22.34,"sixtyDayClose":13.25},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PVLA\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2523194226","title":"Palvella Therapeutics Inc 报告截至 12 月 31 日的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2523194226","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523194226?lang=zh_cn&edition=fundamental","pubTime":"2025-03-31 21:31","pubTimestamp":1743427909,"startTime":"0","endTime":"0","summary":"Palvella Therapeutics Inc 报告截至 12 月 31 日的季度业绩 - 收益摘要Palvella Therapeutics Inc PVLA.OQ报告了截至12月31日的季度调整后每股亏损2.72美元，高于去年同期的每股亏损3.70美元。Palvella Therapeutics Inc 报告的季度每股收益为亏损 2.72 美元。该公司当季亏损 607 万美元。Palvella Therapeutics Inc 的股价本季度上涨了 134.2%。华尔街对 Palvella Therapeutics Inc 的 12 个月目标价中位数为 44.50 美元。)季度末预计 实际超过、达到、未达到2024 年 12 月 31 日 -0.64-2.72未达到(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250331:nL3T3QE0UM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PVLA","BK4139"],"gpt_icon":0},{"id":"2522579539","title":"Palvella Therapeutics Inc 预计每股亏损67美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2522579539","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522579539?lang=zh_cn&edition=fundamental","pubTime":"2025-03-28 20:40","pubTimestamp":1743165608,"startTime":"0","endTime":"0","summary":"Palvella Therapeutics Inc 预计每股亏损67美分 - 财报前瞻Palvella Therapeutics Inc PVLA.OQ PVLA.O将于3月31日公布截至2024年12月31日的财报，预计该公司的季度收入将出现下降。华尔街对 Palvella Therapeutics Inc 的 12 个月目标价中位数为 44.00 美元，高于其最后收盘价 27.76 美元。如有任何其他问题或反馈，请联系 RefinitivNewsSupport@thomsonreuters.com。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250328:nL3S3QB0ZJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PVLA"],"gpt_icon":0},{"id":"2522538100","title":"嗡嗡声--美国股票走势-OrganiGram, Phillips 66, SurgePays","url":"https://stock-news.laohu8.com/highlight/detail?id=2522538100","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522538100?lang=zh_cn&edition=fundamental","pubTime":"2025-03-26 23:45","pubTimestamp":1743003917,"startTime":"0","endTime":"0","summary":".N美国东部时间11:30，道琼斯工业平均指数.DJI上涨0.06%，报42,612.53点。标准普尔500指数.SPX下跌0.54%，报5745.76点；纳斯达克综合指数.IXIC下跌1.18%，报18057.35点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250326:nL3S3Q91B9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0477156953.USD","BK4076","WOR","CTAS","SG9999001176.USD","FCX","ALNY","RIO.UK","SARO","IE00BLSP4239.USD","LU0320765059.SGD","SCCO","SPWH","ACRV","ANET","BK4130","SF","PVLA","VVPR","VVX","IE00B19Z3B42.SGD","LU0348723411.USD","MPWR","BEDU","RILY","DLTR","GWRS","SURG","LU1941712264.USD","CHWY","PTPI","BHP.AU","RIO.AU","PAYX","BK4585","IE0008368304.USD","BBIO","WVE","AEP","IE00B42XCP33.USD","PSX","WING","HUMA","JKS","GCTS"],"gpt_icon":1},{"id":"2522853713","title":"BUZZ-Stifel给予Palvella \"买入 \"评级，看好皮肤治疗前景","url":"https://stock-news.laohu8.com/highlight/detail?id=2522853713","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522853713?lang=zh_cn&edition=fundamental","pubTime":"2025-03-26 22:53","pubTimestamp":1743000790,"startTime":"0","endTime":"0","summary":"BUZZ-Stifel给予Palvella \"买入 \"评级，看好皮肤治疗前景3月26日 -  ** 券商 Stifel 开始覆盖药物开发商 Palvella Therapeutics PVLA.O，给予 \"买入 \"评级，目标价 45 美元。** 新PT较该股上次收盘价上涨65  ** Stifel认为PVLA有潜力建立一个罕见皮肤病治疗组合，\"这些治疗组合的总价值可达数十亿美元\"。** Stifel 指出，该公司的凝胶 QTORIN 优化了皮肤深层的给药效果，患者耐受性高。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250326:nL3S3Q919H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PVLA"],"gpt_icon":0},{"id":"2522900617","title":"美国研究综述-Carvana、CrowdStrike、Viasat","url":"https://stock-news.laohu8.com/highlight/detail?id=2522900617","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522900617?lang=zh_cn&edition=fundamental","pubTime":"2025-03-25 23:09","pubTimestamp":1742915378,"startTime":"0","endTime":"0","summary":"美国研究综述-Carvana、CrowdStrike、Viasat路透社3月25日 - 华尔街证券分析师周二调整了对几家美国上市公司的评级和目标价，其中包括 Carvana、Crowdstrike 和 Viasat。要闻  * Carvana Co CVNA.N：摩根士丹利将其评级从等权上调至增持 * CrowdStrike CRWD.O：BTIG将其评级从中性上调至买入 * Moleculin Biotech Inc MBRX.O：Maxim Group将其评级从 \"持有 \"上调至 \"买入\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250325:nL3T3Q812X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0306807586.USD","LU1621768115.EUR","BK4123","LU0225284248.USD","LU1066053197.SGD","LU0266013472.USD","AVTX","VZ","LU0128526141.USD","LU1366192091.USD","LU0314104364.USD","BK4088","LU2065731478.USD","LEN","KBH","AXTA","IE00BSNM7G36.USD","FRPT","LU0321505439.SGD","PCTY","LXEO","LU0054578231.USD","BK4561","DNB","WING","BK4115","LU1066051225.USD","LU1621767810.EUR","BK4585","PVLA","LU0098860793.USD","LU1066051811.HKD","BK4213","LU0320765646.SGD","BK4023","FOA","LNSR","SM","BK4559","BK4139","LU0985481810.HKD","BK4209","LU0053671581.USD","LU1699723380.USD","LU0868494617.USD","LU1571399168.USD","BK4534","LU1861217088.USD","LU1914381329.SGD","BK4229"],"gpt_icon":0},{"id":"2522609353","title":"美国研究综述-美国金融公司、SM 能源、Verizon","url":"https://stock-news.laohu8.com/highlight/detail?id=2522609353","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522609353?lang=zh_cn&edition=fundamental","pubTime":"2025-03-25 15:26","pubTimestamp":1742887560,"startTime":"0","endTime":"0","summary":"美国研究综述-美国金融公司、SM 能源、Verizon路透社3月25日 - 华尔街证券分析师周二调整了对几家美国上市公司的评级和目标价，其中包括美国金融公司、SM 能源公司和威瑞森公司。要闻  * 美国金融公司FOA.N：雷蒙德-詹姆斯将目标股价从27美元上调至30美元 * SM Energy Co SM.N：Stephens 将目标价从 57 美元上调至 66 美元 * Verizon VZ.N：加拿大皇家银行将目标价从42美元上调至45美元以下是路透社周二报导的美国公司研究行动摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250325:nL3T3Q80FG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LXEO","BK4229","LU0098860793.USD","BK4209","IE00BSNM7G36.USD","LU1162221912.USD","LU1861220207.SGD","LU1571399168.USD","LNSR","LU2360107671.USD","BK4596","LU1621768206.USD","BK4088","BK4115","SM","LU0266013472.USD","AVTX","BK4130","DNB","KBH","VZ","FOA","WING","LU0225771236.USD","LEN","LU1941712264.USD","BK4534","LU0320765646.SGD","AXTA","LU0321505439.SGD","LU0942090050.USD","PVLA","LU1621768115.EUR","LU1621767737.EUR","LU0006061336.USD","LU1066053197.SGD","LU0054578231.USD","BK4139","BK4550","BK4213","PCTY","LU1585245621.USD","LU1621767810.EUR","LU1699723380.USD","FRPT","BK4515","BK4533","BK4581","BK4109","BK4082"],"gpt_icon":0},{"id":"2509407655","title":"Palvella Therapeutics(PVLA.US)获TD Cowen首次覆盖，给予买入评级, 目标价44.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2509407655","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509407655?lang=zh_cn&edition=fundamental","pubTime":"2025-02-05 20:11","pubTimestamp":1738757515,"startTime":"0","endTime":"0","summary":"Palvella Therapeutics(PVLA.US)获TD Cowen首次覆盖，给予买入评级, 目标价44.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/05201147968471.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LENZ","PVLA","TD"],"gpt_icon":0},{"id":"2494585747","title":"美国研究综述-苹果、EverQuote、联合健康","url":"https://stock-news.laohu8.com/highlight/detail?id=2494585747","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2494585747?lang=zh_cn&edition=fundamental","pubTime":"2024-12-26 21:03","pubTimestamp":1735218224,"startTime":"0","endTime":"0","summary":"    路透12月26日 - 华尔街证券分析师周四调整了对苹果、EverQuote 和 UnitedHealth 等多家美国上市公司的评级和目标价。要闻  * 苹果公司  ：Wedbush将目标价从300美元上调至325美元 * EverQuote Inc   ：雷蒙德-詹姆斯将目标价从 \"跑赢大盘 \"上调至 \"强烈买入\"。* Kemper Corp   ：雷蒙德-詹姆斯将目标价从75美元上调至82美元 * Palvella Therapeutics Inc：H.C. Wainwright给予买入评级 * Progressive Corp   ：Raymond James将其评级从 \"市场表现 \"上调至 \"跑赢大盘\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0820561818.USD","LU1235295455.SGD","LU1642822529.SGD","LU0289960550.SGD","LU0672654240.SGD","SG9999002232.USD","PVLA","LU0256863902.USD","LU0096362180.USD","LU0203347892.USD","AAPL","LU0820562030.AUD","LU2023250330.USD","ACVA","LU0122379950.USD","LU2242650005.HKD","LU0079474960.USD","BK4532","KMPR","SGRY","LU0029864427.USD","LU1839511570.USD","SG9999003800.SGD","RAPT","LU1244550494.USD","PGR","LU2360106780.USD","IE00B7SZL793.SGD","LU0175139822.USD","LU1291159041.SGD","HGTY","AVXL","LU2092937148.SGD","MACW.SI","SGXZ81514606.USD","LU2592432038.USD","LU0127658192.USD","IE00B4R5TH58.HKD","UNH","LU0976567544.SGD","IE00B7KXQ091.USD","LU1670627923.USD","EVER","LU1506573853.SGD","LU0345768740.USD","LU1582987597.SGD","LU0149725797.USD","LU2087625088.SGD","IE0003U64NQ7.SGD","BK4588"],"gpt_icon":1}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":8}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PVLA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-31","symbol":"PVLA","fiscalQuarterEnding":"2024/12","expectedEps":-0.39,"name":null,"time":"盘前","type":"earning","dateTimestamp":1743393600000,"reportTimeType":"pre","actualEps":4},{"market":"US","date":"2024-11-13","symbol":"PVLA","fiscalQuarterEnding":"2024/09","expectedEps":null,"name":null,"time":"盘后","type":"earning","dateTimestamp":1731474000000,"reportTimeType":"post","actualEps":-2.19},{"market":"US","date":"2024-08-14","symbol":"PVLA","fiscalQuarterEnding":"2024/06","expectedEps":null,"name":null,"time":"盘后","type":"earning","dateTimestamp":1723608000000,"reportTimeType":"post","actualEps":-2.76},{"market":"US","date":"2024-05-15","symbol":"PVLA","fiscalQuarterEnding":"2024/03","expectedEps":null,"name":null,"time":"盘后","type":"earning","dateTimestamp":1715745600000,"reportTimeType":"post","actualEps":-3.95},{"market":"US","date":"2024-04-23","symbol":"PVLA","defaultRemindTime":1713879000000,"type":"split","dateTimestamp":1713844800000,"forFactor":80,"toFactor":1,"ratio":80}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PVLA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PVLA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.125,"buy":0.875,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.875,"analysts":8,"updateTime":1742961600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PVLA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PVLA","date":"2025-04-01","current":44.513093,"percent":0.935484,"low":19.083855,"twenty":20.931809,"median":29.89804,"eighty":43.520732,"high":46.119317,"avg":30.09317,"sd":9.446978,"marketCap":314084382},"quantilePoints":[{"date":"2025-01-03","current":19.083855,"twenty":19.083855,"median":19.083855,"eighty":19.083855,"marketCap":134655684},{"date":"2025-01-10","current":22.662078,"twenty":19.083855,"median":20.077806,"eighty":23.120091,"marketCap":159903624},{"date":"2025-01-17","current":21.024047,"twenty":19.083855,"median":21.024047,"eighty":22.483962,"marketCap":148345678},{"date":"2025-01-24","current":20.658273,"twenty":19.395558,"median":20.960435,"eighty":22.003685,"marketCap":145764777},{"date":"2025-01-31","current":21.469337,"twenty":19.914003,"median":20.93658,"eighty":21.408905,"marketCap":151487644},{"date":"2025-02-07","current":23.854819,"twenty":20.19708,"median":20.960435,"eighty":22.191343,"marketCap":168319605},{"date":"2025-02-14","current":31.806426,"twenty":20.537409,"median":21.047902,"eighty":23.471552,"marketCap":224426140},{"date":"2025-02-21","current":30.216104,"twenty":20.626467,"median":21.159225,"eighty":24.999851,"marketCap":213204833},{"date":"2025-02-28","current":29.977556,"twenty":20.64237,"median":22.089563,"eighty":29.977556,"marketCap":211521636},{"date":"2025-03-07","current":38.072292,"twenty":20.658273,"median":23.043756,"eighty":30.804523,"marketCap":268638089},{"date":"2025-03-14","current":43.224933,"twenty":20.674177,"median":23.473142,"eighty":31.806426,"marketCap":304995124},{"date":"2025-03-21","current":43.622513,"twenty":20.674177,"median":24.864674,"eighty":35.527777,"marketCap":307800451},{"date":"2025-03-28","current":44.147319,"twenty":20.912725,"median":26.844623,"eighty":43.224933,"marketCap":311503482},{"date":"2025-04-01","current":44.513093,"twenty":20.931809,"median":29.89804,"eighty":43.520732,"marketCap":314084382}],"updateTime":1743655064655}}}